{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:50:07Z","timestamp":1761875407923,"version":"build-2065373602"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To assess treatment responses to sibutramine and weight management in diabetic patients during the lead\u2010in period of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    SCOUT is an ongoing, prospective, randomized, double\u2010blind, placebo\u2010controlled outcome trial in cardiovascular high\u2010risk overweight\/obese patients. A total of 10 742 patients received single\u2010blind sibutramine and individualized weight management during the 6\u2010week lead\u2010in period; 84% had a history of type 2 diabetes mellitus and additional co\u2010morbidities.\n                    <jats:italic>Post\u2010hoc<\/jats:italic>\n                    analyses assessed anthropomorphic and vital sign responses between patients with and without diabetes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Concomitant antidiabetic medication use was reported by 86% of the diabetic patients (approximately 30% required insulin\u2013alone or in combination). Body weight and waist circumference decreased in diabetic patients: median 2.1 kg; 2.0 cm (both men and women); for those on insulin: 1.9 kg; 1.5\/2.0 cm (men\/women); without insulin: 2.3 kg; 2.0 cm (both men and women); blood pressure (BP) was also reduced (median systolic\/diastolic 3.5\/1.0 mmHg) with larger reductions in diabetic patients who were hypertensive and\/or lost the most weight (&gt;5%). In diabetic patients who entered with BP at target (&lt;130\/&lt;85 mmHg) but did not lose weight (N = 245), increases of 3.5\/2.0 mmHg were observed. Non\u2010diabetic patients had greater weight losses (2.5 kg) but smaller reductions in BP (systolic\/diastolic \u22122.5\/\u22120.5 mmHg). Pulse rate increases were less in diabetic vs. non\u2010diabetic patients (1.5 vs. 2.0 bpm).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    In these high\u2010risk diabetic patients, sibutramine and lifestyle modifications for 6 weeks resulted in small, but clinically relevant, median reductions in body weight, waist circumference and BP. A small median increase in pulse rate was recorded.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2009.01090.x","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T21:22:58Z","timestamp":1253136178000},"page":"26-34","source":"Crossref","is-referenced-by-count":13,"title":["Weight and blood pressure response to weight management and sibutramine in diabetic and non\u2010diabetic high\u2010risk patients: an analysis from the 6\u2010week lead\u2010in period of the sibutramine cardiovascular outcomes (SCOUT) trial"],"prefix":"10.1111","volume":"12","author":[{"given":"L. F.","family":"Van Gaal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. D.","family":"Caterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Finer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Torp\u2010Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. P. T.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the SCOUT Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,22]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature05487"},{"key":"e_1_2_8_3_2","first-page":"88","article-title":"Guidelines on diabetes, pre\u2010diabetes and cardiovascular diseases; ESC and EASD guidelines","volume":"28","year":"2007","journal-title":"Eur Heart J"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00481.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066254"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066603"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-789X.2007.00425.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm217"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3281fc975a"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.10.5.563"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00701.x"},{"key":"e_1_2_8_13_2","unstructured":"National Institute for Health and Clinical Excellence. Clinical Guideline 43 (CG 43). Obesity: the prevention identification assessment and management of overweight and obesity in adults and children. December 2006. Available from URL:http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG43NICEGuideline.pdf. pg.53. Accessed December 2008."},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.3.316"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441801"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.676379"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67663-5"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2004.95"},{"issue":"1","key":"e_1_2_8_20_2","first-page":"38S","article-title":"Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal\/visceral fat reduction?","volume":"22","author":"Van Gaal LF","year":"1998","journal-title":"Int J Obes"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjr.0000199496.23838.83"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7160.703"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.02.002"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0483-1"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806359"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm217"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2009.01090.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2009.01090.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:41:40Z","timestamp":1761874900000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2009.01090.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1463-1326.2009.01090.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01090.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2009,12,22]]}}}